Magellan Life Sciences (Pre-Seed)

Funding Details
Date Award
May 13, 2024
Vertical
Alt Protein
Funding URL
View Funding Page

Company Info
Founders
Abhiram Dukkipati, Laxmi Wagle
Company Description
Magellan Life Sciences is a synthetic biology company that discovers and develops plant-inspired proteins for commercial applications in food and beverage industries. The sweet-tasting protein Brazzein (the leading product from our pipeline) holds significant commercial potential as a next-gen protein sweetener that is 1,200 times sweeter than sugar, zero calories, and pH and heat stable. Our XSeed platform is a proprietary synthetic biology-based platform built upon a vast library of proprietary synthetic-secretion signal molecules.
Market
Future Food
Location
United Kingdom

Links
Back to Home Back to Alt Protein Deals View Funding Announcement